For more details on the courses, please refer to the Course Catalog
| Code | Course Title | Credit | Learning Time | Division | Degree | Grade | Note | Language | Availability |
|---|---|---|---|---|---|---|---|---|---|
| PHR5258 | Research Intensive Class on Pharmaceutical Science6 | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course focuses on the analysis of research trends in the field of pharmaceutical science, pharmacokinetics, and analytical chemistry and the progress of research results conducted by graduate students. | |||||||||
| PHR5259 | Pharmacology Seminar | 3 | 6 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| The object of the course is to the study of integrated view of pharmacology. The format will consist of student-led discussions based on original research papers and supplemented with pertinent review articles of pharmacology. | |||||||||
| PHR5260 | Biopharmaceuticals | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This class focuses on general introduction of bio-therapeutics and in-depth study of therapeutic antibodies. The first half of the class deals with introduction of bio-pharmaceuticals including nucleic acids, proteins and gene therapy and thereof therapeutic principles. The last half discus about representative therapeutic antibodies thereof mode of action and market trends. | |||||||||
| PHR5261 | Peptide Pharmaceuticals | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This class focuses on peptide therapeutics which are emerging drugs. The conventional peptide chemistry and cutting edge chemistry related to peptide preparation are covered by the lectures and seminar. Preparation and application for therapeutics of peptide libraries are discussed in-depth. | |||||||||
| PHR5262 | Molecular Toxicology | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course explores molecular actions of toxicants and mechanisms of their adverse health effects. The students are expected to develop a broad understanding of xenobiotics metabolism, biomarkers of toxicity, animal models of toxicology, techniques used in detection of toxicant and molecular changes caused by environmental chemicals and toxicants. This course will consist of lectures and discussions. | |||||||||
| PHR5264 | Special Topics in Pharmacology1 | 3 | 6 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| This course covers the biochemical and pharmacological action mechanisms of drugs. Molecular pharmacology emphasized. | |||||||||
| PHR5265 | Special Topics in Pharmacology2 | 3 | 6 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| A detailed discussion of current concepts of recept or interactions, enzymology and cell structure and function as they apply to an understanding of hormone, neurotransmitter, drug and toxin actions. | |||||||||
| PHR5266 | Pharmacology Research | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course will examine the research methods commonly used by pharmacologists, the description of relevant tools and techniques of evaluation. | |||||||||
| PHR5267 | Molecular Pharmacology | 3 | 6 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| This course will examine the current state of knowledge regarding the action of selected drugs at the molecular level and the use of drugs as probes to explore cellular structure and function. | |||||||||
| PHR5269 | Special Topics in Clinical Pharmacology | 3 | 6 | Major | Master/Doctor | Pharmacy | Korean | Yes | |
| This course covers training on structure information, drug mechanisms, and cases applied to clinical practice for recently developed drugs used in clinical treatment. | |||||||||
| PHR5270 | Advanced Epigenetics | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course introduces the latest research trends on epigenetic mechanisms that regulate gene expression without changing DNA sequences. In addition, this course will discuss the epigenetic analysis techniques and the latest research trends of therapeutic strategies using various epigenomic mechanisms. | |||||||||
| PHR5271 | Neurochemistry | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| A great deal of interest has been directed toward neurochemistry because the field not only became the major subject of advanced life sciences but also has been directly involved in the search of the mental phenomena. Neurochemistry is the study of chemicals, including neurotransmitters and other molecules such as psychohormons and neuropeptides, that control and influence the biology of the nervous system. This field within neuroscience examines how neurochemicals influence the operation of neurons, synapses, neural networks, and neuronal disorders. In neurochemistry class, we will analyze the biochemistry and molecular biology of organic compounds in the nervous system, and their roles in such neural processes including cortical plasticity, neurogenesis, neural differentiation, and neurodegeneration. | |||||||||
| PHR5272 | Next Generation Molecular Immunology | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course introduces the latest molecular immunological findings and the process of changing key technologies and paradigms of advanced bio-pharmaceuticals. It also introduces the current status and significance of the latest immunotherapeutics such as immune checkpoint inhibitors, CAR-T (Chimeric antigen receptor-T), which utilize immune mechanisms | |||||||||
| PHR5273 | Advanced Molecular Immunology | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course introduces the newly discovered immunological molecular mechanisms in modern humoral and cellular immune responses. In addition, students will acquire knowledge about their discovery process and application principles. | |||||||||
| PHR5274 | Advanced Regulatory Immunology | 3 | 6 | Major | Master/Doctor | Pharmacy | - | No | |
| This course introduces the latest immune regulatory mechanisms such as Regulatory T cell, Regulatory B cell, Immune check point. In addition, it will introduce the autoimmune diseases caused by their abnormal regulation and the development of immunomodulators for the immune diseases. | |||||||||